377 related articles for article (PubMed ID: 33430702)
21.
Xiao F; Dong F; Li X; Li Y; Yu G; Liu Z; Wang Y; Zhang T
Front Pharmacol; 2022; 13():902337. PubMed ID: 35979230
[No Abstract] [Full Text] [Related]
22. Quantitative changes in selected bacteria in the stool during the treatment of Crohn's disease.
Salamon D; Gosiewski T; Krawczyk A; Sroka-Oleksiak A; Duplaga M; Fyderek K; Kowalska-Duplaga K
Adv Med Sci; 2020 Sep; 65(2):348-353. PubMed ID: 32590155
[TBL] [Abstract][Full Text] [Related]
23. Effects of a synbiotic on the fecal microbiome and metabolomic profiles of healthy research cats administered clindamycin: a randomized, controlled trial.
Whittemore JC; Stokes JE; Price JM; Suchodolski JS
Gut Microbes; 2019; 10(4):521-539. PubMed ID: 30709324
[TBL] [Abstract][Full Text] [Related]
24. Metaproteomics reveals persistent and phylum-redundant metabolic functional stability in adult human gut microbiomes of Crohn's remission patients despite temporal variations in microbial taxa, genomes, and proteomes.
Blakeley-Ruiz JA; Erickson AR; Cantarel BL; Xiong W; Adams R; Jansson JK; Fraser CM; Hettich RL
Microbiome; 2019 Feb; 7(1):18. PubMed ID: 30744677
[TBL] [Abstract][Full Text] [Related]
25. Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD.
Lee T; Clavel T; Smirnov K; Schmidt A; Lagkouvardos I; Walker A; Lucio M; Michalke B; Schmitt-Kopplin P; Fedorak R; Haller D
Gut; 2017 May; 66(5):863-871. PubMed ID: 26848182
[TBL] [Abstract][Full Text] [Related]
26. Characteristics of mucosa-associated gut microbiota during treatment in Crohn's disease.
He C; Wang H; Liao WD; Peng C; Shu X; Zhu X; Zhu ZH
World J Gastroenterol; 2019 May; 25(18):2204-2216. PubMed ID: 31143071
[TBL] [Abstract][Full Text] [Related]
27. The relevance of DHA with modulating of host-gut microbiome signatures alterations and repairing of lipids metabolism shifts.
Yu H; Fang C; Li P; Wu M; Shen S
Eur J Pharmacol; 2021 Mar; 895():173885. PubMed ID: 33482183
[TBL] [Abstract][Full Text] [Related]
28. Impact of Fecal Microbiota Transplantation on Gut Bacterial Bile Acid Metabolism in Humans.
Bustamante JM; Dawson T; Loeffler C; Marfori Z; Marchesi JR; Mullish BH; Thompson CC; Crandall KA; Rahnavard A; Allegretti JR; Cummings BP
Nutrients; 2022 Dec; 14(24):. PubMed ID: 36558359
[TBL] [Abstract][Full Text] [Related]
29. Inter-kingdom relationships in Crohn's disease explored using a multi-omics approach.
Frau A; Ijaz UZ; Slater R; Jonkers D; Penders J; Campbell BJ; Kenny JG; Hall N; Lenzi L; Burkitt MD; Pierik M; Darby AC; Probert CSJ
Gut Microbes; 2021; 13(1):1930871. PubMed ID: 34241567
[TBL] [Abstract][Full Text] [Related]
30. Treatment with infliximab for pediatric Crohn's disease: Nationwide survey of Japan.
Hosoi K; Ohtsuka Y; Fujii T; Kudo T; Matsunaga N; Tomomasa T; Tajiri H; Kunisaki R; Ishige T; Yamada H; Arai K; Yoden A; Ushijima K; Aomatsu T; Nagata S; Uchida K; Takeuchi K; Shimizu T
J Gastroenterol Hepatol; 2017 Jan; 32(1):114-119. PubMed ID: 27478130
[TBL] [Abstract][Full Text] [Related]
31. Altered gut microbiota and short chain fatty acids in Chinese children with autism spectrum disorder.
Liu S; Li E; Sun Z; Fu D; Duan G; Jiang M; Yu Y; Mei L; Yang P; Tang Y; Zheng P
Sci Rep; 2019 Jan; 9(1):287. PubMed ID: 30670726
[TBL] [Abstract][Full Text] [Related]
32. Habitual animal fat consumption in shaping gut microbiota and microbial metabolites.
Wan Y; Tong W; Zhou R; Li J; Yuan J; Wang F; Li D
Food Funct; 2019 Dec; 10(12):7973-7982. PubMed ID: 31776537
[TBL] [Abstract][Full Text] [Related]
33. Heavy metal exposure causes changes in the metabolic health-associated gut microbiome and metabolites.
Li X; Brejnrod AD; Ernst M; Rykær M; Herschend J; Olsen NMC; Dorrestein PC; Rensing C; Sørensen SJ
Environ Int; 2019 May; 126():454-467. PubMed ID: 30844581
[TBL] [Abstract][Full Text] [Related]
34. Metabonomics and the Gut Microbiome Associated With Primary Response to Anti-TNF Therapy in Crohn's Disease.
Ding NS; McDonald JAK; Perdones-Montero A; Rees DN; Adegbola SO; Misra R; Hendy P; Penez L; Marchesi JR; Holmes E; Sarafian MH; Hart AL
J Crohns Colitis; 2020 Sep; 14(8):1090-1102. PubMed ID: 32119090
[TBL] [Abstract][Full Text] [Related]
35. An Integrated Fecal Microbiome and Metabolomics in T2DM Rats Reveal Antidiabetes Effects from Host-Microbial Metabolic Axis of EtOAc Extract from
Shao J; Liu Y; Wang H; Luo Y; Chen L
Oxid Med Cell Longev; 2020; 2020():1805418. PubMed ID: 32566075
[TBL] [Abstract][Full Text] [Related]
36. Correlation between altered gut microbiota and elevated inflammation markers in patients with Crohn's disease.
Hu J; Cheng S; Yao J; Lin X; Li Y; Wang W; Weng J; Zou Y; Zhu L; Zhi M
Front Immunol; 2022; 13():947313. PubMed ID: 36045690
[TBL] [Abstract][Full Text] [Related]
37. Sleep fragmentation increases blood pressure and is associated with alterations in the gut microbiome and fecal metabolome in rats.
Maki KA; Burke LA; Calik MW; Watanabe-Chailland M; Sweeney D; Romick-Rosendale LE; Green SJ; Fink AM
Physiol Genomics; 2020 Jul; 52(7):280-292. PubMed ID: 32567509
[TBL] [Abstract][Full Text] [Related]
38. Diet-induced remission in chronic enteropathy is associated with altered microbial community structure and synthesis of secondary bile acids.
Wang S; Martins R; Sullivan MC; Friedman ES; Misic AM; El-Fahmawi A; De Martinis ECP; O'Brien K; Chen Y; Bradley C; Zhang G; Berry ASF; Hunter CA; Baldassano RN; Rondeau MP; Beiting DP
Microbiome; 2019 Aug; 7(1):126. PubMed ID: 31472697
[TBL] [Abstract][Full Text] [Related]
39. Altered gut microbiota and microbial metabolism in children with hepatic glycogen storage disease: a case-control study.
Wang Y; Liu H; Dong F; Xiao Y; Xiao F; Ge T; Li D; Yu G; Zhang T
Transl Pediatr; 2023 Apr; 12(4):572-586. PubMed ID: 37181017
[TBL] [Abstract][Full Text] [Related]
40. Microbiome-Metabolomics Analysis of the Impacts of
Wang L; Cao L; Chang Y; Fu Y; Wang Y; Zhang K; Zhang S; Zhang L
Microbiol Spectr; 2023 Feb; 11(1):e0217522. PubMed ID: 36533947
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
